397 related articles for article (PubMed ID: 1663200)
1. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole in neutropenic patients.
van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
[TBL] [Abstract][Full Text] [Related]
3. [Systemic mycotic infections].
Meunier F
Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
[TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Van Cutsem J
Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
8. [Commonly used antifungal agents in the treatment of systemic mycoses].
Berenguer Berenguer J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
[No Abstract] [Full Text] [Related]
9. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
Van Cutsem J
Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
[TBL] [Abstract][Full Text] [Related]
10. [In-vitro and in-vivo activity of itraconazole].
Van Cutsem J
Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Hostetler JS; Stevens DA
Med Klin (Munich); 1991 Dec; 86 Suppl 1():8-10. PubMed ID: 1663205
[TBL] [Abstract][Full Text] [Related]
12. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Caselli D; Aricò M; Michelone G; Cavanna C; Nespoli L; Burgio GR
Microbiologica; 1990 Oct; 13(4):347-51. PubMed ID: 1965007
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of pulmonary mycoses].
Schaberg T; Lode H
Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
[No Abstract] [Full Text] [Related]
14. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Thunnissen PL; Sizoo W; Hendriks WD
Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
[TBL] [Abstract][Full Text] [Related]
16. [Mycoses as opportunistic infections in AIDS patients].
Viviani MA
Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
18. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Van t Wout JW; Mattie H; van Furth R
Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
Viscoli C; Castagnola E
Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
